- Teaching Notes
- Supplementary Resources
In early spring of 2013, Ren Jianxin, the General Manager of ChemChina and Chairman of Bluestar, was reading a brief report on the Nanjing Adisseo project. He was delighted that the Nanjing Adistar project had successfully passed acceptance tests and entered trial operation. It would be put into production in the middle of the year. It was already seven years since he led the Bluestar management team in acquiring the French Adisseo Company in January 2006. Many people inside and outside the industry had congratulated him at the time. During the following years, he and other executives of the company had worked hard to integrate and develop Adisseo. In particular, the completion of the Nanjing Adistar project marked the landing of world leading methionine production technology in China, providing a substantial increase in Adisseo's methionine production capacity. The Board of Directors of Bluestar would be reviewing Adisseo in a few days. What new opportunities and challenges did Adisseo face? Which should be Adisseo's future strategic development plans?